EBP1 was identified as a protein that interacts with the ErbB-3 receptor and possibly contributes to transducing growth regulatory signals. The existence of EBP1 homologs across species from simple eukaryotes to humans and its wide tissue expression pattern suggest that EBP1 acts as a general signaling molecule. We provide evidence that EBP1 is localized to the cytoplasm and to the nucleolus, and that its nucleolar localization requires amino-acid sequences present at both the aminoand carboxy-terminus of the molecule. We also show that EBP1 overexpression inhibits proliferation of human fibroblasts, and that this effect is linked to its nucleolar localization. Using mass spectrometry we demonstrate that EBP1 is part of ribonucleoprotein complexes and associates with different rRNA species. It is becoming clear that cell growth and proliferation are actively coordinated with rRNA processing and ribosome assembly. Our findings indicate that EBP1 is a nucleolar growth-regulating protein, and we propose that it could represent a new link between ribosome biosynthesis and cell proliferation.
Introduction
Attempts to understand the pathways that regulate rRNA synthesis and ribosome assembly have led to the discovery of a complex scenario that requires the activity of different RNA-processing enzymes (including endonucleases, exonucleases, helicases), small nucleolar ribonucleoproteins (snoRNPs), GTPases and many other accessory factors (see review articles by Kressler et al., 1999; Warner, 2001; Fatica and Tollervey, 2002) . While in yeast these processes are now relatively well understood, in higher eukaryotes an extensive analysis is still lacking and the identity of non-ribosomal accessory proteins has not been clearly established.
In mammalian cells, rRNA is transcribed in the nucleolus by RNA polymerase I (Pol I), as a single 47S precursor (pre-rRNA) and subsequently processed to give the mature 18S, 5.8S and 28S species. The 5S rRNA is transcribed by RNA polymerase III (Pol III) from an independent transcriptional unit. rRNA precursors initially associate with ribosomal proteins to form a 90S pre-ribosomal particle that is subsequently cleaved into 60S and 40S pre-subunits. After a series of nucleolar RNA-processing reactions that lead to rRNA maturation, the 60S pre-subunit is translocated first from the nucleolus to the nucleoplasm, where most of the assembly factors are released, and it is then translocated to the cytoplasm where most non-ribosomal proteins are removed to give the mature 60S subunit (Nissan et al., 2002) . The 40S pre-subunit is initially processed in the nucleolus and it is then translocated to the cytoplasm, where the late steps of small subunit biogenesis take place (Schafer et al., 2003) .
The nucleolus is known to be the main site of ribosome biosynthesis (Scheer and Hock, 1999) yet it has also become clear that it may play a role in mRNA transport (Schneiter et al., 1995) , as well as a repository for proteins that regulate a variety of biological processes like cell division and aging (Guarente, 1997) . The presence in nucleoli of mitogenic growth factors and of growth factor-related proteins has also been described (Pederson, 1998) . However, it is currently unclear how the crosstalk between cell growth and nucleolus is achieved.
EBP1 was identified as an ErbB-3-binding protein in a yeast two-hybrid screening . It was found to bind the juxta-membrane cytoplasmic domain of unphosphorylated ErbB-3, and heregulin (ErbB-3 ligand) treatment of AU565 breast carcinoma cell line induced EBP1 dissociation from the receptor and its subsequent translocation to the nucleus . It was therefore initially proposed that EBP1 is a modulator of the ErbB-3 transduction pathway, mediating the biological effects of heregulin. Ectopic expression of EBP1 in ErbB-2-, ErbB-3-expressing breast carcinoma cell lines inhibited colony formation, induced a decrease in proliferation rate and resulted in a partial accumulation of cells in the G2/M phase of the cell cycle .
Its pattern of expression in cells of both epithelial and mesenchymal origin and its conservation throughout evolution suggested that EBP1 could be involved downstream of multiple signal transduction pathways (Xia et al., 2001a, b) . EBP1 can bind pRb and inhibit E2F1-mediated transcription (Xia et al., 2001a; Zhang et al., 2003) . Moreover, it was also recently shown that EBP1 binds to the androgen receptor and mediates its transcriptional activity (Zhang et al., 2002) .
Here we present evidence that EBP1 is a nucleolar and cytoplasmic protein and through mutation analysis we have identified amino-acid residues required for its nucleolar localization. We show that ectopic expression of EBP1 is able to reduce the proliferation rate of nonimmortalized human fibroblasts and that nucleolar localization is linked to its ability to inhibit growth.
We demonstrate that EBP1 is part of ribonucleoprotein (RNP) complexes, which may represent pre-ribosome subunits, and is able to associate with mature and precursor rRNA species. These results indicate that EBP1 is an RNA-binding growth-regulating nucleolar protein that could inhibit cell proliferation by modulating rRNA processing and/or ribosome assembly.
Results

EBP1 is ubiquitously expressed and localizes to both the nucleolus and the cytoplasm
To characterize EBP1, we generated a polyclonal antiserum and tested it by immunoblotting in different cell lines. EBP1 is a 394 amino-acid protein that migrates on SDS-PAGE at approximately 48 kDa, and is encoded by a gene called PA2G4 (Lamartine et al., 1997) . All cell lines analysed (either primary, immortalized or transformed) expressed comparable levels of a 48 kDa band (Figure 1a ). In mouse tissues we detected EBP1 as a single band, except in salivary glands, intestine, kidney and heart where faster-migrating species, which could represent tissue-specific isoforms, were detected (Figure 1b) .
Using the EBP1 antiserum in immunofluorescence experiments, in HeLa, NIH3T3 and EpH4 cells, we found that endogenous EBP1 was localized to both the cytosol and the nucleus, and within the nucleus, staining accumulated in regions that appeared to be nucleoli ( Figure 1c) . The nucleolar localization of EBP1 was confirmed by confocal analysis of HeLa cells transfected with an epitope-tagged EBP1 (Flag-EBP1) stained with anti-Flag antibody and an antiserum that recognizes NPM, a nucleolar protein (Borer et al., 1989) . As shown in the images of Figure 1d , the two proteins colocalized to nucleoli.
To further substantiate this finding, we performed subfractionation of HeLa cell lysates and assayed the various fractions obtained for EBP1, NPM (nucleolar marker) and laminin (nucleoplasmic marker) immunoreactivity. EBP1 was detected both in the NP40 soluble and insoluble cytosolic fractions, in the nucleoplasmenriched fraction and in pure nucleoli (Figure 1e ). NPM was enriched in the nucleolar fraction, while laminin was only detected in the nucleoplasm, confirming that the nucleolar fraction was not contaminated by nucleoplasm and that a fraction of EBP1 was truly associated with the nucleolar material. (a) Immunoblotting of whole cell extracts (30 mg) of the indicated cell lines using an anti-EBP1 polyclonal antiserum; as a specificity control a blot was also performed on an extract from FLAG-EBP1-overexpressing HeLa cells. (b) Immunoblotting in total extract (50 mg) of the indicated mouse tissues. (c) Immunofluorescence staining of endogenous EBP1 in HeLa, NIH3T3 and EpH4 cells. (d) HeLa cells, transfected with a Flag-EBP1 construct, were examined by confocal immunofluorescence analysis after staining with antibodies to Flag (red) and the nucleolar marker protein NPM (green). Colocalization between EBP1 and NPM was revealed in the merged images (yellow). (e) HeLa cells were subjected to a fractionation protocol that allowed enrichment of cytoplasmic (NP40-soluble and -insoluble), nucleoplasmic and nucleolar components (0.88 M sucrose supernatant and pellet, respectively). Samples corresponding to an equivalent number of cells were immunoblotted for EBP1, laminin and NPM EBP1 and growth regulation M Squatrito et al N-terminal and the C-terminal regions of EBP1 are both required for its proper localization To identify signals required for the nucleolar localization of EBP1, we transfected HeLa cells with plasmids encoding full-length EBP1 or various deletion mutants as GFP fusion proteins (Figure 2a) . Carrier GFP was detected in the cytoplasm and the nucleoplasm (data not shown), while full-length EBP1 (1-394)-GFP fusion accumulated both in nucleoli and in the cytoplasm, being poorly detectable in the nucleoplasm (Figure 2b ). This was comparable to the localization of both endogenous and Flag-tagged EBP1 (see above). Mutants lacking the amino-terminal 48 amino-acid residues and beyond (48-394, 183-394, 301-394) were all detected in the cytoplasm and were excluded from the nucleus. On the contrary, mutants 1-48, 1-182 and 1-300 accumulated in the nucleoplasm, while being clearly excluded from nucleoli ( Figure 2b ). Interestingly, mutant 1-367 distributed between the cytoplasm and the nucleoplasm and, in some cells, partially accumulated in nucleoli. These data demonstrate that the first 48 amino acids and a region between amino acids 301 and 394 are both required for proper localization of EBP1. The amino-terminal sequences could be responsible for localizing EBP1 to the nucleus, while the C-terminal ones for nuclear export and nucleolar localization and/or retention.
Nucleolar localization (NoLS) and nucleolar retention signal (NoRS) are ill-defined sequences; they are usually rich in arginine and lysine residues and often overlap with nuclear localization signals (NLSs) (Rizos et al., 2000; Lixin et al., 2001; Catez et al., 2002) . To map amino-acid residues critical for nucleolar accumulation, we mutated lysine and arginine residues in the regions identified by the deletion analysis. Plasmids encoding the GFP fusion mutants indicated in Figure 2c were transfected in HeLa cells and tested by fluorescence confocal analysis. As shown in Figure 2d , the mutant K20A-K22A was excluded from nucleoli and it did not colocalize with the nucleolar marker NPM (red color in the merged image). The mutant R30A-R33A had an intracellular distribution undistinguishable from that of full-length EBP1, while the mutant R364A-K365A was only partially localized to nucleoli (orange color in the merged image) (Figure 2d ). It has been shown that ectopic expression of EBP1 in tumor cell lines results in a decreased proliferation rate and inhibition of colony formation. To test whether the nucleolar localization of EBP1 was required for its growth suppressive activity, we infected human fibroblasts, strain WI38, with retrovirus vectors encoding EBP1 either wild type or the point mutants K20A-K22A, R364A-K365A or the deletion mutant 1-300. Cell viability and growth were measured both by trypan blue exclusion (data not shown) and MTT assay ( Figure 3a ). As expected, uninfected cells (data not shown) or those infected with an empty vector proliferated at similar rates, while overexpression of the full-length EBP1 protein inhibited cell proliferation. The mutant K20A-K22A, which fails to accumulate in the nucleoli, did not delay cell cycle progression. The R364A-K365A mutant that is still partially retained in the nucleolus inhibited growth similar to full-length protein.
The deletion mutant 1-300 that localized to the nucleus but was excluded from nucleoli did not affect cell proliferation. It appears therefore that nuclear localization might not be sufficient for EBP1 to exert its growth inhibitory activity, which on the other hand would require its association with nucleolar components. Immunoblotting was performed to confirm that EBP1 and its mutants were expressed at similar levels in the infected cells ( Figure 3b ). As previously shown , a cell cycle profile of EBP1-overexpressing cells, determined by flow cytometry, revealed an accumulation of cells in G2/ M phase and a considerable increase in the number of apoptotic cells, compared to vector-infected cells ( Figure 3c ). WI38 cells infected with R364A-K365A mutant showed a cell cycle profile similar to EBP1 wild type, while the two mutants K20A-K22A and 1-300 had a profile similar to control-infected cells.
Isolation and characterization of human EBP1 ribonucleoprotein complexes
To further understand the function of EBP1, we searched for interacting proteins by immunoprecipitation and mass spectrometry analysis of co-precipitating bands. We transfected HeLa cells with the Flag-EBP1-expressing construct and a cell extract was made from these cells and immunoprecipitations performed using an anti-Flag affinity resin. Since EBP1 is localized to both the cytoplasm and the nucleolus, we decided to use a nonfractionated cell extract. A typical staining pattern of the immunoprecipitation on SDS-PAGE is shown in Figure 4a . We could detect at least 16 protein bands on a colloidal-blue-stained gel. We were able to exclude nonspecific bands by performing a control immunoprecipitation using cells transfected with the expression vector lacking the EBP1 cDNA insert. We excised bands from the gel and subjected them to nanoelectrospray/ MALDI mass spectrometry. All of the identified bands correspond to known proteins. In all, 13 ribosomal proteins were identified: P0, L4, L8, L7a, L15, L18, L18a, L21, L11, L12, L28, L27, P2 and L30. Nonribosomal proteins were nucleolin, topoisomerase I, poly (A)-binding protein 2, acetylated histone H1.1 and histone H1 2/4.
To check whether the EBP1 protein complexes were held together by the presence of RNA, before performing immunoprecipitations, we treated a cell extract with ribonuclease A. Most proteins in the EBP1-binding complexes were dissociated by ribonuclease treatment (Figure 4b ). This observation indicates that RNA integrity is required for stable association of the proteins Nucleolin is one of the most abundant components of the nucleolus in growing eucaryotic cells. It interacts transiently with pre-rRNA early on during rRNA transcription to facilitate assembly of ribosomal proteins in the nucleus, whereas it is not detectable in mature cytoplasmic ribosomes (Bourbon et al., 1983) . With the exception of ribosomal proteins P2 and histone H1, all EBP1-interacting proteins have previously been identified as components of a nucleolin-binding RNP complex (Bouvet et al., 1998; Yanagida et al., 2001) . Nucleolin is able to interact directly with ribosomal and nonribosomal proteins like NPM, but its interaction with other proteins is mediated by binding to RNA molecules (Pinol-Roma, 1999) . To map the domain in EBP1 required for nucleolin association, we performed an in vitro binding experiment using purified GST-EBP1 fusion proteins, either the full-length protein (aa 1-394) or its deletion mutants (aa 1-300, 301-394, 1-182, 183-394), incubated with a HeLa cell extract. As shown in Figure 4c , the carboxy-terminal 94 amino-acid residues in EBP1 were sufficient for its interaction with nucleolin, and possibly other components of the complex.
In addition, we asked whether nucleolar localization was required for the formation of EBP1 RNP complexes. To perform this experiment, and to avoid losing potential interaction sites at the EBP1 N-terminus, we selected the point mutant K20A-K22A. The K20A-K22A protein immunoprecipitation pattern was substantially different compared to the EBP1 full-length one (Figure 4d) , with complete absence of nucleolin. This indicates a failure of the mutated nucleolusexcluded EBP1 to become part of RNP complexes.
EBP1 associates with rRNA precursors and mature rRNA
Mammalian rRNA is transcribed in the nucleolus as a primary 47S precursor and is subsequently processed to give mature 28S, 18S and 5.8S, as represented in Figure 5a , through the activity of different RNAprocessing enzymes. To test whether EBP1 could be involved in rRNA maturation, we extracted RNA from the EBP1 RNP complexes, and analysed it for the presence of pre-rRNA-processing components. No RNA could be extracted from a control sample. Northern blotting analysis revealed the presence of the mature 28S, 18S and 5.8S rRNAs; in addition, we could also detect 41S, 32S and 12S pre-rRNA species, assigned by the oligo probes for 5 0 ETS, ITS2, 18S, 28S and 5.8S (Figure 5b ). To further characterize the RNA components of EBP1 RNP complexes, the RNAs eluted from the EBP1 immunoprecipitates, and control immunoprecipitations from HeLa cells transfected with vector alone, were 3 0 -end-labeled with [ 32 P]pCp using the T4 RNA ligase and resolved on denaturing polyacrylamide urea-containing gels ( Figure 5c ). As also evidenced above, EBP1 associated with 5.8S; moreover, we could show an interaction with 5S and with an RNA species that appears to be U3 small nucleolar RNA (snoRNA) and other RNA species. This evidence would suggest that EBP1 might act as a cofactor in rRNA processing.
EBP1 contains a s
-like motif
The evidence that EBP1 is able to associate with RNA (this paper and Pilipenko et al., 2000) prompted us to investigate whether it possessed any specific RNAbinding motif. Recently, a short amino-acid sequence, the s 70 -like motif, has been identified in a family of RNA-binding proteins (known as Imp4p superfamily or Brix family) with a suggested role in ribosome biogenesis (Eisenhaber et al., 2001; Wehner and Baserga, 2002 Figure 6a , EBP1 contains an amino-acid sequence (46-64 aa) that fits almost perfectly (five residues out of seven) with the s 70 consensus and shares extensive homology with the motif present in the Imp4p superfamily members, with the exception of a conserved proline in position 8.
Recently, it has been shown that the s 70 -like motif is required for nucleolar localization of the Imp4p protein, since deletion of this domain induced its nuclear relocalization and impaired its interaction with other nucleolar proteins (Granneman et al., 2003) . To test if it was the case also for EBP1, we created an EBP1 mutant (EBP1Ds 70 ) lacking amino acids 46-64, a region containing the putative s 70 -like motif. The GFP-tagged mutant protein EBP1Ds 70 was no longer able to accumulate in the nucleolus and was present only in the cytoplasm (Figure 6b) .
We also tested the effect of the EBP1Ds 70 mutant on cell proliferation and RNP complexes formation. Analogous to what we have shown above for the K20A-K22A mutant, the EBP1Ds 70 mutant did not have any growth-suppressing activity ( Figure 6c ) and failed to form RNP complexes (Figure 6d ).
EBP1 binds directly to RNA
To test a possible direct interaction of EBP1 with RNA and whether or not this involved its s 70 -like motif, we performed an RNA electrophoretic mobility shift assay (EMSA) using recombinant purified GST-EBP1 incubated with a 5S rRNA radiolabeled probe. EBP1 was able to bind to the RNA probe leading to the formation of a slow-migrating complex (Figure 7a, left panel) . Moreover, the formation of the complex between EBP1 and the 5S rRNA probe was efficiently competed in the presence of increasing concentration of the same unlabeled probe, confirming the specificity of the binding (Figure 7a, right panel) .
To test whether the EBP1 amino-acid sequence 46-54, containing a s 70 -like motif, was required for efficient binding with RNA, we also performed the EMSA using the EBP1Ds 70 deletion mutant. This was indeed the case, since, as shown in Figure 7b , the GST-EBP1Ds 70 fusion protein failed to interact with the 5S rRNA probe.
Discussion
Nucleoli are the main site of assembly of ribosomal subunits in eukaryotic cells: rRNAs are synthesized and processed in nucleoli where they associate with more than 80 different ribosomal proteins and with the 5S rRNA to form the nuclear precursors of cytoplasmic 40S and 60S ribosomal subunits (see for review Shaw and Jordan, 1995) . Further evidence indicates that nucleoli are involved in regulating growth and proliferation by acting as a sequestering compartment for regulatory complexes (Hernandez-Verdun et al., 2002) .
In this manuscript, we show that the ErbB-3-binding protein EBP1 is localized to the cytoplasm, accumulates in nucleoli and is almost undetectable in the nucleoplasm. Our results extend published findings that find EBP1 localized to the cytosol and the nucleus of HeLa and AU565 cell lines (Xia et al., 2001a) . Recently, Andersen et al. (2002) and Scherl et al. (2002) have independently identified EBP1 as a component of human nucleoli. Using mass spectrometry they have described a total of 350 different nucleolar proteins, one-third of which are encoded by unknown or uncharacterized genes, one of them being PA2G4.
A detailed analysis of different EBP1 deletion and point mutants identified two regions, the aminoterminal 48 amino acids and the carboxy-terminal region 301-394, as being required for proper localization of EBP1. Deletion of the N-terminal region or generation of a point mutant K20A-K22A, but not R30A-R33A, completely abolishes the nucleolar localization of EBP1. Interestingly, residues K20-K22 but not R30-R33 are strictly conserved in EBP1 homologs from different species (data not shown). These amino-acid sequences could be at least part of an NLS. Furthermore, while the N-terminal deletion mutants 1-48, 1-182 and 1-300 accumulate in the nucleus, they are clearly excluded from the nucleolus. On the contrary, the mutant 1-367 is diffused throughout the cell, and the point mutant R364A-K365A, while still allowing nuclear exclusion, does not efficiently accumulate in the nucleolus. This evidence would suggest that the C-terminus of the protein contains both an NoRS and a nuclear export signal (NES): the first allows the protein to be kept within the nucleolus and the second exports it from the nucleus, excluding it from the nucleoplasm. The presence of separate N-and C-terminal domains controlling nucleolar localization has been described for other proteins including human ARF (Llanos et al., 2001) .
We show that EBP1 overexpression inhibits growth of human fibroblasts. This extends previous observations made in tumor cell lines Yoo et al., 2000; Xia et al., 2001a) , demonstrating that both normal and transformed cells are sensitive to EBP1 over- expression. Most importantly, we observed that the mutant K20A-K22A, which is only cytosolic and not nucleolar, is unable to inhibit proliferation. The failure of an EBP1 mutant protein missing the 72 carboxyterminal residues to inhibit proliferation (Xia et al., 2001a) could be also linked to the fact that the mutant cannot localize to the nucleolus. We have evidence indeed that both the N-terminal and the C-terminal regions of EBP1 are required for correct EBP1 localization and that nucleolar localization is necessary for its growth suppression activity.
Using mass spectrometry, we have identified 17 proteins in EBP1 immunocomplexes, but cannot exclude to have missed others, due to their transient interaction with EBP1 and/or to detection limits with colloidal-blue staining and MALDI spectrometry analysis. Since (a) all the proteins identified are present in the nucleolus, 13 of them being ribosomal proteins of the 60S subunit, (b) they fail to bind to EBP1 upon ribonuclease treatment and (c) they fail to bind to a mutated protein that does not localize to the nucleolus, we can reasonably hypothesize that EBP1 might be involved in the formation of RNP complexes in the nucleolus.
The major component of EBP1-binding complexes is nucleolin (see for review Srivastava and Pollard, 1999) . It has been shown that nucleolin interacts with at least 60 different proteins, 40 of which are ribosomal (Yanagida et al., 2001) , and it has been proposed that it acts as a shuttle for ribosomal proteins from the cytoplasm to the nucleolus and as a binding adapter of ribosomal proteins to rRNA, at a late stage of ribosome biogenesis. Recently, it has been found that preribosomal RNP complexes associate with human Nop56p, a component of the box C/D small RNP complexes involved in pre-rRNA maturation (Hayano et al., 2003) . Proteins we have identified in EBP1 immunocomplexes were also identified in the Nop56p associated pre-ribosomal complexes. The process of ribosome synthesis requires a large number of accessory proteins and is still not entirely understood. Due to the cytosolic and nucleolar localization of EBP1, and because of it being part of RNP complexes and its association with rRNA-processing intermediates, we propose that EBP1 could contribute to ribosome biosynthesis and more specifically to maturation of the 60S subunit.
An analysis of the RNA components that constitute EBP1 RNP complexes demonstrated the presence of both pre-rRNAs (41S, 32S and 12S) and mature rRNAs (28S, 18S, 5.8S and 5S), together with U3 snoRNA and other unidentified RNA molecules. snoRNAs are short (60-300 nt) metabolically stable RNAs, most of them acting as guide RNAs in the post-transcriptional synthesis of 2 0 -O-methylated nucleotides and pseudouridines in rRNAs and other cellular RNAs (see for review Filipowicz and Pogacic, 2002; Kiss, 2002) . snoRNAs bind a set of core proteins and other associated cofactors to form snoRNP particles, of which the best studied is the U3 snoRNP. Yeast U3 particle is a large nucleolar RNP required for pre-18S rRNA processing, comprised of at least 28 physically and functionally associated proteins (Dragon et al., 2002) . Interestingly, one of these components is the Imp4p, the prototype of the Imp4p superfamily, a class of proteins required for ribosome biogenesis, containing the recently identified RNA-binding domain s
70
-like motif, which we have shown to be present also in EBP1.
In yeast, despite the remarkable number of proteins that are involved in pre-rRNA processing, only a few have been demonstrated to bind directly to RNA. The s 70 -like motif has been described as an RNA-binding domain sufficient to confer RNA-binding activity in three different members (Imp4p, Rpf1p and Rpf2p) of the Imp4p superfamily (Wehener and Baserga, 2002) . Yeast mutant strains expressing either Rpf1p or Rpf2p missing the s 70 -like motif are not viable. Moreover, it has been recently described that deletion of the s 70 -like motif in human Imp4 protein excludes it from the nucleolus and impairs its ability to bind Imp3 and Mpp10 (Granneman et al., 2003) . Here, we show that EBP1 contains a sequence similar to the s 70 -like motif and that deletion of this domain prejudices its nucleolar localization. This delocalized EBP1 mutant protein does not exert growth suppression activity and fails to form the RNP complex, confirming that EBP1 nucleolar localization, RNP complex formation and proliferation inhibition are tightly related. Furthermore, we demonstrated that EBP1-RNA interaction is direct and not mediated by other proteins and that binding requires an intact s 70 -like motif. Interestingly, EBP1 have also been previously described as an IRES-specific cellular trans-acting factor (ITAF 45) that mediates cap-independent translation of specific viral IRESs (Internal Ribosomal Entry Site) (Pilipenko et al., 2000) . Viral mRNAs are naturally uncapped at their 5 0 end and present complex features in their 5 0 untranslated region (UTR). Translation initiation is mediated by specific IRES structures, a process that requires a canonical set of eucaryotic initiation factors (eIFs) and a series of message-specific cellular IRES trans-acting factors (ITAFs). An increasing number of cellular mRNAs have been discovered to contain IRESs in the 5 0 UTR and, in response to different types of stress, translation initiation of these mRNAs is switched from a cap-dependent to a capindependent mechanism (Hellen and Sarnow, 2001 ). All ITAFs identified are RNA-binding proteins that bind structural elements in different IRESs and possibly keep these RNAs in an active status (Pilipenko et al., 2000; Mitchell et al., 2003) .
Along this line of evidence it is possible that EBP1 might act as an RNA chaperone that binds to different pre-rRNAs leaving them in an open conformation, thereby facilitating the activity of other RNA-processing enzymes.
Ribosome biosynthesis is the major energy-consuming process for unicellular organisms such as yeast (Warner, 1999) , and is becoming clear that the rate of ribosome production is strictly coordinated with cell growth and proliferation. Compared to yeast, only few non-ribosomal nucleolar proteins, involved in ribosome production, have been characterized in mammalian cells. A mutated form of the nucleolar protein Bop1, a WD40 protein involved in rRNA processing, blocks prerRNA cleavage, interfering in multiple steps with rRNA maturation, and prevents the formation of mature 60S ribosome subunits inducing a powerful yet reversible p53-dependent cell cycle arrest in NIH3T3 (Pestov et al., 2001; Strezoska et al., 2002) . Recently, it was also shown that the nucleolar ARF tumor suppressor protein is able to inhibit rRNA processing, affecting it at multiple cleaving steps (Sugimoto et al., 2003) . The authors show that these effects require ARF nucleolar localization, but do not require either p53 or MDM2, suggesting that inhibiting normal rRNA processing could activate one or more checkpoints, either p53-dependent or p53-independent. EBP1 overexpression induces a slight reduction (E20%) in both 28S rRNA and 18S rRNA (data not shown), suggesting, together with the evidence of EBP1 association with different pre-rRNA species, a possible role in regulating the intermediate and late steps of rRNA processing.
EBP1 is a growth-regulating nucleolar protein that is part of an RNP complex and associates with different RNA molecules, and we speculate that its ability to inhibit growth could be linked to a negative effect on the normal rRNA processing and/or ribosome assembly. However, further work will be required to clarify its molecular mechanism of action.
Materials and methods
Cell culture and transfection
HeLa, EpH4 and NIH3T3 cells were grown at 371C in a 5% CO 2 atmosphere in Dulbecco's modified Eagle's medium (DMEM) (Euroclone) supplemented with 2 mM L-glutamine (Euroclone), and with 10% bovine calf serum (Hyclone), 5% fetal bovine serum and 10% bovine calf serum, respectively. Other cell lines were grown according to the ATCC instructions.
Cells were transiently transfected using calcium phosphate co-precipitation and harvested 24 h post-transfection. Where indicated cells were transfected with Lipofectamine (Invitrogen, Life Technologies) according to the manufacturer's instructions.
Cell viability analysis by MTT assay
Cellular proliferation was measured by reduction of MTT, which corresponds to living cell number and metabolic activity (Mosmann, 1983) . After puromycin selection, infected WI38 cells were plated at 10 4 cells/well in 12-well plates. Each day of the growth curve, 200 ml of 2.5 mg/ml MTT solution (SIGMA) was added to each well. After 2 h of incubation, the medium was removed and 1 ml of DMSO was added. The absorbance of each well was measured at 554 nm using a microplate reader MRX (Dynatech Laboratories) according to the manufacturer's protocol.
Construction of deletion mutants and GST fusion protein production
The full-length cDNA was generated by RT-PCR starting from total RNA of MDA-MB 231 using sense (5 0 PA2G4 5 0 -CGGAATTCCGGCGGCTCAGGGGAAACGAGG) and antisense (3 0 PA2G4 5 0 -CCGCTCGAGCTGGGGAGATGG GACGCACC) primers flanked at their 5 0 ends by EcoRI and XhoI consensus sequences, respectively. The purified PCR product was cloned into the EcoRI-XhoI sites of pcDNA 3.1 FlagA, pCDNA3 (Invitrogen) and pGEX-4T-2 (AmershamPharmacia), and into the EcoRI-SalI sites of pEGFP-C3 (Clontech) and pBabePuro. Deletion mutants were generated by PCR with template EBP1 cDNA as follows: 50-394, sense 5 0 -CTGTGTGAGAAAGGTGATGCC and antisense 5 0 -TGGGGAGATGGGACGCACC; 301-394, sense 5 0 -CTGC TGCAACCATTTAATGTTCTC and antisense 5 0 -TGGGGA GATGGGACGCACC; 1-48, sense 5 0 -CGGCGGCTCA GGGGAAACGAGG and antisense 5 0 -CAGGCTGAGTA CCGACACACCTGAG; 1-184, sense 5 0 -CGGCGGCTCA GGGGAAACGAGG and antisense 5 0 -ACCTTCTATTGG CGTGCAGTTAAATGAG; 1-300, sense 5 0 -CGGCGGC TCAGGGGAAACGAGG and antisense 5 0 -TTCATGTTT GGCGCACTCCAC; 1-367, sense 5 0 -CGGCGGCTCAGGG GAAACGAGG and antisense 5 0 CTGGGTTTTTCGACTT GCAGAAC. All the sense and antisense primers were flanked at their 5 0 ends by EcoRI and XhoI consensus sequences, respectively, and were cloned into the same vectors of the fulllength cDNA. EBP1 point mutants were generated using the QuickChange Site-directed Mutagenesis kit (Stratagene) using the following primers: K20A-K22A sense 5 0 -CTGGT CGTGACCGCGTATGCGATGGGGGGCGAC and antisense 5 0 -GTCGCCCCCCATCGCATACGCGGTCACGAC CAG primers; for R30A-R33A sense 5 0 -CTTCCACCAAG GACGCAAGTACCGCGTTGGCGATGTCG and antisense 5 0 -CGACATCGCCAACGCGGTACTTGCGTCCTTGGTG GAAG primers; for R364A-K365A sense 5 0 -CTCCAGA GTTCTGCAAGTGCAGCAACCCAGAAAAAGAAA and antisense 5 0 -tttctttttctgggttgctgcacttgcagaactctggag primers. The EBP1Ds 70 deletion mutant was generated using the following primers 5 0 phosphorylated: 5 0 -TACCGACA CACCTGAGCTAG and 5 0 -AAGAAAGAAAAGGAAAT GAAGAAAGGT. All constructs were verified by DNA sequencing.
GST wild-type or mutant EBP1 fusion proteins were expressed in the BL21 codon plus bacterial strain, purified on glutathione-sepharose beads (Amersham-Pharmacia) and analysed on SDS-PAGE.
Cell extraction and immunoblot analysis
Cells harvested by trypsinization were washed twice with PBS, resuspended in RIPA lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 1% deoxycholate, 50 mM NaF, 1 mM DTT), supplemented with 1 mg/ml aprotinin, 1 mg/ml leupeptin and 10 mM PMSF and incubated on ice for 15 min. Cells lysates were centrifuged at maximum speed and the supernatants were recovered. Samples were assayed for protein concentration using the Bradford method. Equal amounts of samples were resolved by SDS-PAGE and proteins transferred onto nitrocellulose membranes. After blocking with 5% dry non-fat milk in Tris-buffered saline (TBS) containing 0.05% Tween, membranes were incubated with primary antibodies and subsequently with peroxidaseconjugated secondary antibodies. Immunoreactive bands were visualized by ECL (Amersham-Pharmacia) on autoradiography films.
An EBP1 rabbit polyclonal antiserum was generated (Eurogentec) by immunizing rabbits against a mixture of an amino-terminal (MSGEDEQQEQTIAEC) and a carboxyterminal EBP1 peptide (NPTSGETLEENEAGD). The antiserum was utilized at a dilution of 1 : 8000. In addition, mouse anti-Flag (M2, Sigma), mouse anti-NPM (a gift of Prof. PG Pelicci) and mouse anti-nucleolin (Santa Cruz) antibodies were used.
Autoradiography films and colloidal-blue-stained gels were scanned using SNAPS-SCAN1236 (Agfa).
Immunofluorescence
HeLa cells (7 Â 10 4 ) were transfected by calcium phosphate co-precipitation pcDNA 3.1-Flag-EBP1 or pEGFP-EBP1, full length and mutants. The cells were fixed 48 h after transfection with 4% paraformaldehyde (in PBS) for 10 min, permeabilized with 0.2% Triton X-100 for 10 min, blocked in 2% BSA in PBS and stained for 1 h with the same antibodies used for immunoblot analysis, except from a rabbit polyclonal anti-NPM (a gift of Prof. PG Pelicci) and a mouse anti-p14 ARF (Ab-2 Neomarker). Fluorescein isothiocyanate (FITC)-conjugated anti-rabbit, Cy3-conjugated anti-mouse or anti-rabbit were used as secondary antibodies. Immunofluorescence analysis was performed with an Olympus BX61, and confocal images were obtained with an Olympus 1X70 microscope and a Biorad MRC 1024ES laser.
RNA extraction, Northern blot hybridization and RNA end-labeling HeLa cells were transfected with a pcDNA 3.1-Flag-Ebp1 expression construct. RNA was extracted from immunocomplexes using Trizol (Invitrogen), fractionated on 1% agarose gels containing 0. tion in prehybridization solution, the RNA blots were hybridized to the probes at 421C overnight in the prehybridization solution containing 1 Â 10 6 cpm. The blots were washed and exposed to the PhosphorScreen (Molecular Dynamics Japan Inc., Tokyo, Japan).
For the analysis of small RNA species, the RNA was 3 0 -endlabeled with [ 32 P]pCp (Amersham) using T4 RNA ligase (Roche) and separated on 6% polyacrylamide gel containing 7 M urea. The gel was then dried and the RNA visualized by PhosphorScreen (Molecular Dynamics Japan Inc., Tokyo, Japan).
Electrophoretic mobility shift assay
The 5S RNA-specific probe was prepared from total RNA extracted from HeLa cells using Trizol reagent (Invitrogen) following the manufacturer's protocol.
The RNA was end-labeled with T4 RNA ligase (Roche) and [g-32 P]pCp (Amersham) and separated on 6% polyacrylamide gel containing 7 M urea; the 5S RNA was then eluted from the gel in elution buffer (2 M ammonium acetate, 1% SDS, 1 mM EDTA in DEPC-treated water), precipitated, resuspended and quantified. In the same urea gel, an equal quantity of total RNA not labeled was loaded to permit the elution of 5S RNA cold probe.
Different amounts of GST-Ebp1 were incubated with 25 000 cpm of 5S probe in 20 ml of binding buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.4, 0.5 mM EDTA) for 30 min at room temperature. Samples were loaded on a 5% native polyacrylamide gel, fixed in 10% acetic acid-10% ethanol, vacuum dried and analysed by PhosphorScreen.
